TMCnet News

Redistributed Cardiac/Vascular X-Ray Procedures Take the Edge off Threats from New Modalities
[November 15, 2004]

Redistributed Cardiac/Vascular X-Ray Procedures Take the Edge off Threats from New Modalities

PALO ALTO, Calif. --(Business Wire)-- Nov. 15, 2004 -- New modalities, such as computed tomography (CT) and magnetic resonance imaging (MRI), are increasingly making inroads into the space traditionally dominated by cardiac and vascular X-ray-based diagnostic procedures. Vascular imaging, or imaging of the blood vessels of the human body using contrast agents and x-rays has been the gold standard for decades.

New analysis from Frost & Sullivan (, U.S. Cardiac and Vascular X-ray Equipment Markets, reveals that the market achieved revenue worth $775.4 million in 2003. It is estimated to reach $1,006.4 million in 2010.

If you are interested in an analysis overview which provides manufacturers, end-users and other industry participants an overview, summary, challenges and latest coverage of U.S. Cardiac and Vascular X-ray Equipment Markets, please send an email to Danielle White - North American Corporate Communications, at [email protected] with the following information: Full name, Company Name, Title, Contact Tel Number, Contact Fax Number, Email. Upon receipt of the above information, an overview will be emailed to you.

Over the last year or so, traditional X-ray-based diagnostic procedures are increasingly being substituted by modalities such as CT and MR, each with specific strengths and options for improving the diagnostic accuracy.

The degree to which this trend will affect market revenue growth within the cardiac and vascular X-ray market is debatable. Observers point to the fact that cardiac X-ray may still be used to verify the results of diagnostic exams performed by CT and MR imaging.

The overall impact of the infringement by other modalities is weakened by the expectation that increased influence of other modalities on the diagnostic side will generate an increase in the number of interventional cases to be treated.

"It is believed that modalities such as cardiovascular CT or MR will simply serve to redistribute the X-ray procedure volume from a diagnostic case load to an interventional one," says Frost & Sullivan Research Analyst, Seemeen Mirza.

Nevertheless, this trend poses a number of questions for manufacturers to address. First, a reduction in diagnostic procedures will affect the utilization and viability of cath labs. This is likely to affect the purchase of equipment. Second, if customers have a greater number of technological options available to them, their choice of equipment may include a different mix of products. Manufacturers will need to be very cognizant of the changing purchasing trends in the cardiac X-ray and vascular markets.

The strategy to address the impact of new, less invasive imaging modalities in the X-ray imaging space needs a two-pronged approach. First, manufacturers need to flex their marketing muscle to promote the systems that are being impacted by the new modalities. The emerging technologies such as MR and CT are considerably expensive.

Customers may be willing to re-consider or postpone their investment decisions if the price differential between X-ray systems and CT, for instance, is widened. Second, manufacturers need to assess the trends from a product development perspective.

For most market observers, cardiovascular CT is perceived as the next modality to have a significant influence in cardiology. Investment in tracking and developing the modalities of the future will be an important long-term driver of competitiveness for the key players.

U.S. Cardiac and Vascular X-ray Equipment Markets, a part of the Medical Imaging subscription, provides data and analyses of the U.S. cardiac and vascular X-ray equipment markets with emphasis on cardiac catheterization laboratories, which are a key user segment. The cardiology market has been segmented into interventional cardiology, pediatric cardiology, and electrophysiology (EP). Vascular X-ray systems market has been divided into interventional radiology, neuroradiology, and vascular surgery. Interviews are available to the press.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. Its advisory expertise integrates growth consulting, growth partnership services and corporate management training to identify and develop opportunities for clients. While serving clientele ranging from virtually every Global 1000 to emerging companies, Frost & Sullivan's comprehensive industry coverage includes a global perspective of all vertical and horizontal industries. Its unique coverage combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit U.S. Cardiac and Vascular X-ray Equipment Markets F172

Keywords in this release: cardiac X-ray equipment, vascular X-ray, U.S., cardiac catheterization, cath, interventional procedures, computed tomography, CT, magnetic resonance, MR, interventional cardiology, pediatric cardiology, electrophysiology, EP, interventional radiology, neuroradiology, vascular surgery, digital flat panel technology, research, information, market, trends, technology, service, forecast

[ Back To's Homepage ]